Search results
Merck's (MRK) Ebola Vaccine Gets Approval for Kids in Europe
Zacks via Yahoo Finance· 9 months agoMerck MRK announced that the European Commission has approved its vaccine for Ebola, called Ervebo,...
J&J and Merck Ebola vaccines produce lasting antibodies in children and adults -studies
Reuters via Yahoo News· 1 year agoEbola vaccines developed by Johnson & Johnson and Merck & Co produced virus-fighting antibodies and...
Merck to donate Ebola vaccine candidate for research program in Uganda
Reuters via Yahoo News· 2 years agoThe investigational vaccine that will be donated to IAVI is similar to Merck's Ervebo vaccine, which...
West Africa-Based Studies Show JNJ, Merck's Ebola Vaccines Provide Lasting Antibodies
Benzinga via Yahoo Finance· 1 year agoEbola vaccines developed by Johnson & Johnson (NYSE: JNJ) and Merck & Co Inc (NYSE: MRK) produced...
Three experimental Ebola vaccines head to Uganda
The Hill via Yahoo News· 2 years agoStory at a glance There have been 129 confirmed cases in the Ebola outbreak in Uganda and 37 deaths so far. The outbreak has reached the country’s...
Uganda receives 1,200 doses of Ebola vaccine candidates for trials
Reuters via Yahoo News· 1 year agoA shipment of Ebola vaccine candidates set to be used in a clinical trial have arrived in Uganda,...
Uganda declares itself Ebola-free after swiftly turning tide on outbreak
Reuters via Yahoo News· 1 year agoKAMPALA (Reuters) -Uganda on Wednesday declared the end of a nearly four-month Ebola outbreak that...
Ebola Fast Facts
CNN via Yahoo News· 12 months agoHere’s a look at Ebola, a virus with a high fatality rate that was first identified in Africa in 1976. Facts Ebola hemorrhagic fever is a disease caused by one of five different Ebola viruses ...
Merck Partner Joins Forces With Emergent Bio To Increase Access To Ebola Treatment
Benzinga via Yahoo Finance· 2 years agoEmergent BioSolutions Inc (NYSE: EBS) has agreed to create a collaboration with Ridgeback...
Pharma Stock Roundup: J&J to End Hypertension Study & Other Regulatory Updates
Zacks via Yahoo Finance· 9 months agoThis week, J&J JNJ announced its decision to end a late-stage study evaluating its drug Opsumit...